Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Cannasat and IntelGenx to codevelop novel cannabinoid-based product

March 22, 2007

Dharma's IDDS effective in reducing pain in phase II study

March 22, 2007

Enrollment completed in phase III Alzheimer's trial of Flurizan

March 22, 2007

Zogenix closes USD 10 million financing deal

March 22, 2007

AM-111 otoprotective in acute labyrinthitis model

March 22, 2007

FDA approves Keppra for primary generalized tonic-clonic seizures

March 21, 2007

Ramelteon filed in E.U. for primary insomnia

March 21, 2007

Novel drug promotes differentiation of neural stem cells via modulation of the Notch/Hes pathway

March 21, 2007

NAP reduces tau hyperphosphorylation in vivo

March 21, 2007

New vaccine approach for the treatment of Alzheimer's disease

March 21, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...